Starpharma Holdings Valuation
| SPHRY Stock | USD 3.55 0.75 26.79% |
At this time, the company appears to be overvalued. Starpharma Holdings has a current Real Value of $2.7 per share. The regular price of the company is $3.55. Our model measures the value of Starpharma Holdings from inspecting the company fundamentals such as Price To Earning of 43.64 X, return on equity of -0.29, and Current Valuation of 123.62 M as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Starpharma Holdings' price fluctuation is very risky at this time. Calculation of the real value of Starpharma Holdings is based on 3 months time horizon. Increasing Starpharma Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Starpharma otc stock is determined by what a typical buyer is willing to pay for full or partial control of Starpharma Holdings. Since Starpharma Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Starpharma OTC Stock. However, Starpharma Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.55 | Real 2.7 | Hype 3.55 |
The intrinsic value of Starpharma Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Starpharma Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Starpharma Holdings helps investors to forecast how Starpharma otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Starpharma Holdings more accurately as focusing exclusively on Starpharma Holdings' fundamentals will not take into account other important factors: About Starpharma Holdings Valuation
Our relative valuation model uses a comparative analysis of Starpharma Holdings. We calculate exposure to Starpharma Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Starpharma Holdings's related companies.Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company was founded in 1996 and is headquartered in Abbotsford, Australia. Starpharma Hlds operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 50 people.
8 Steps to conduct Starpharma Holdings' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Starpharma Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Starpharma Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Starpharma Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Starpharma Holdings' revenue streams: Identify Starpharma Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Starpharma Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Starpharma Holdings' growth potential: Evaluate Starpharma Holdings' management, business model, and growth potential.
- Determine Starpharma Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Starpharma Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Starpharma Holdings Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 408.4 M | |
| Forward Price Earnings | 333.3333 | |
| Retained Earnings | -218.6 M |
Additional Tools for Starpharma OTC Stock Analysis
When running Starpharma Holdings' price analysis, check to measure Starpharma Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Starpharma Holdings is operating at the current time. Most of Starpharma Holdings' value examination focuses on studying past and present price action to predict the probability of Starpharma Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Starpharma Holdings' price. Additionally, you may evaluate how the addition of Starpharma Holdings to your portfolios can decrease your overall portfolio volatility.